Composition

Hepatitis B (rDNA) vaccine (adsorbed) Suspension for Injection. Each dose (1 mL) contains: Hepatitis B surface antigen^1, 2 20 micrograms 1. Adsorbed on aluminium hydroxide, hydrated Total: 0.50 milligrams Al^3+ 2. Produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA technology The vaccine is highly purified, and exceeds the WHO requirements for recombinant hepatitis B vaccines. No substances of human origin are used in its manufacture  

ATC Code/ATCvet Code

J07BC01  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 x 1 mL (in pre-filled syringe)  

Product Description

Suspension for Injection. Turbid white suspension. Upon storage, a fine white deposit with a clear colorless supernatant may be observed

Manufacturer Name

GlaxoSmithKline Biologicals

Manufacturer Country

FRANCE  

Approval Date

2022-01-31  

Expiry Date

2027-12-15